Abstract
Rationale The results of recent in vitro studies have underscored the important role that activation of CB1 receptors has on GABAergic activity in brain areas associated with memory. Objectives The primary purpose of this study was to test the hypothesis that the memory disruptive effects of Δ9-tetrahydrocannabinol (Δ9-THC) in vivo are mediated through GABAergic systems. Conversely, we also evaluated whether blocking CB1 receptor signaling would alter memory deficits elicited by GABA agonists. Methods The GABAA antagonist bicuculline and GABAB antagonist CGP 36742 were evaluated for their ability to ameliorate Δ9-THC-induced deficits in a mouse working memory Morris water maze task. Mice were also assessed in a T-maze task, as well as non-cognitive behavioral assays. Additionally, the effects of GABAA and GABAB agonists were assessed in either CB1 (−/−) mice or wild type mice treated with the CB1 antagonist SR 141716. Results Memory deficits resulting from 10 mg/kg Δ9-THC in the Morris water maze were completely reversed by bicuculline, though unaffected by CGP 36742. Bicuculline also blocked the disruptive effects of Δ9-THC in the T-maze, but failed to alter non-mnemonic effects of Δ9-THC. Although CB1 (−/−) mice exhibited supersensitivity to muscimol-induced water maze deficits compared with wild type control mice, muscimol elicited virtually identical effects in SR 141716-treated and vehicle-treated wild type mice. Conclusions This is the first demonstration of which we are aware showing that GABAA receptors may play a necessary role in Δ9-THC-induced memory impairment in whole animals.

This publication has 28 references indexed in Scilit: